164 related articles for article (PubMed ID: 20307549)
1. Receptor cross-talk in angiogenesis: mapping environmental cues to cell phenotype using a stochastic, Boolean signaling network model.
Bauer AL; Jackson TL; Jiang Y; Rohlf T
J Theor Biol; 2010 Jun; 264(3):838-46. PubMed ID: 20307549
[TBL] [Abstract][Full Text] [Related]
2. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
3. Crossing paths with Notch in the hyper-network.
Hurlbut GD; Kankel MW; Lake RJ; Artavanis-Tsakonas S
Curr Opin Cell Biol; 2007 Apr; 19(2):166-75. PubMed ID: 17317139
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
[TBL] [Abstract][Full Text] [Related]
5. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis.
Samani AA; Brodt P
Surg Oncol Clin N Am; 2001 Apr; 10(2):289-312, viii. PubMed ID: 11382588
[TBL] [Abstract][Full Text] [Related]
6. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.
Gomez-Duran A; Carvajal-Gonzalez JM; Mulero-Navarro S; Santiago-Josefat B; Puga A; Fernandez-Salguero PM
Biochem Pharmacol; 2009 Feb; 77(4):700-12. PubMed ID: 18812170
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
[TBL] [Abstract][Full Text] [Related]
8. Regulation of vascular morphogenesis by Notch signaling.
Roca C; Adams RH
Genes Dev; 2007 Oct; 21(20):2511-24. PubMed ID: 17938237
[TBL] [Abstract][Full Text] [Related]
9. Integrin beta4 signaling promotes tumor angiogenesis.
Nikolopoulos SN; Blaikie P; Yoshioka T; Guo W; Giancotti FG
Cancer Cell; 2004 Nov; 6(5):471-83. PubMed ID: 15542431
[TBL] [Abstract][Full Text] [Related]
10. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
[TBL] [Abstract][Full Text] [Related]
11. [Role of ephrins in regulation of tumour cell migration].
Wybieralska E; Łaczna E; Madeja Z
Postepy Biochem; 2009; 55(2):153-62. PubMed ID: 19824471
[TBL] [Abstract][Full Text] [Related]
12. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2003 May; 90(5):449-58. PubMed ID: 12850768
[TBL] [Abstract][Full Text] [Related]
13. Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species.
Wu WS; Wu JR; Hu CT
Cancer Metastasis Rev; 2008 Jun; 27(2):303-14. PubMed ID: 18299806
[TBL] [Abstract][Full Text] [Related]
14. Retinoid receptor cross-talk in respiratory epithelium cancer chemoprevention.
Karamouzis MV; Papavassiliou AG
Trends Mol Med; 2005 Jan; 11(1):10-6. PubMed ID: 15649817
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
16. Clinical, cellular, and molecular aspects of cancer invasion.
Mareel M; Leroy A
Physiol Rev; 2003 Apr; 83(2):337-76. PubMed ID: 12663862
[TBL] [Abstract][Full Text] [Related]
17. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization.
Zheng C; Qiu Y; Zeng Q; Zhang Y; Lu D; Yang D; Feng J; Yan X
Int J Biochem Cell Biol; 2009 Nov; 41(11):2163-72. PubMed ID: 19782948
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction cross-talk during colorectal tumorigenesis.
Liu X; Lazenby AJ; Siegal GP
Adv Anat Pathol; 2006 Sep; 13(5):270-4. PubMed ID: 16998321
[TBL] [Abstract][Full Text] [Related]
19. Ion channels and the hallmarks of cancer.
Prevarskaya N; Skryma R; Shuba Y
Trends Mol Med; 2010 Mar; 16(3):107-21. PubMed ID: 20167536
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
